IDXX vs TBI · P/E 40, rev $2.36B vs rev $841.6M
IDEXX Laboratories Inc (IDXX) versus TrueBlue Inc (TBI) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
TrueBlue Inc (TBI) is a staffing & employment services company listed on NYSE.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported TBI revenue for 2026-06-28 was $841.6M. Net income was -$23.2M. TBI currently screens at market cap $205.8M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. TBI currently screens at market cap $205.8M.
Not investment advice. Open the IDXX and TBI stock pages for the full models.
Not investment advice.